Molbio Diagnostics IPO is to open on August 10, 2026. It is a Mainboard IPO that will raise ₹939.70 crores. The Molbio Diagnostics IPO price band is fixed at ₹768 to ₹807 with a market lot of 18 Shares.
Molbio Diagnostics IPO GMP Live Rates day by day with Kostak rates.
| Date | IPO GMP | GMP Trend | Gain | Last Updated |
| 17 August | ₹120 | 🔴 | 14.87% | 09:41 |
| 14 August | ₹156 | 🟢 | 19.33% | 15:04 |
| 13 August | ₹156 | 🟢 | 19.33% | 16:26 |
| 12 August | ₹138 | 🟢 | 17.10% | 15:52 |
| 11 August | ₹127 | 🔴 | 15.74% | 18:47 |
| 10 August | ₹132 | 🔴 | 16.36% | 14:56 |
| 8 August | ₹180 | 🔴 | 22.30% | 16:48 |
| 7 August | ₹220 | 🟢 | 27.26% | 16:45 |
| 6 August | ₹170 | 🟢 | 21.06% | 16:41 |
| 5 August | ₹- | – | -% | 16:00 |
| 4 August | ₹- | – | -% | 16:57 |
Molbio Diagnostics IPO Details
| IPO Open Date | August 10, 2026 |
| IPO Close Date | August 12, 2026 |
| Face Value | ₹1 Per Equity Share |
| IPO Price Band | ₹768 to ₹807 Per Share |
| Issue Size | Approx ₹939.70 Crores |
| Fresh Issue | Approx ₹200 Crores |
| Offer for Sale: | Approx 91,66,000 Equity Shares |
| Issue Type | Book built Issue |
| IPO Listing | BSE, NSE |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Molbio Diagnostics IPO Dates
| IPO Open Date: | August 10, 2026 |
| IPO Close Date: | August 12, 2026 |
| Basis of Allotment: | August 13, 2026 |
| Refunds: | August 14, 2026 |
| Credit to Demat Account: | August 14, 2026 |
| IPO Listing Date: | August 17, 2026 |
Business Overview
Molbio Diagnostics is an innovative point-of-care (POC) diagnostics company that develops affordable, rapid, and accurate diagnostic solutions for infectious and non-communicable diseases. Its flagship product, Truenat, is a portable, battery-powered PCR testing platform that delivers results within an hour. Designed for use in resource-limited settings, it enables quick and decentralised disease diagnosis at the point of care.
Through its wholly owned subsidiary, Bigtec Labs, Molbio has strong research and development capabilities focused on creating diagnostic platforms for point-of-care (POC) testing. From product development to large-scale deployment, the company aims to improve access to reliable and affordable healthcare for everyone.
Molbio Diagnostics IPO GMP aka Grey Market Premium FAQs:
What is Molbio Diagnostics IPO GMP Today?
What is Molbio Diagnostics IPO Expected Returns?
Disclaimer:
- IPO Grey Market Premium (Molbio Diagnostics IPO GMP) mention is valid for the specific date as mentioned in the header.
- We are not buying and selling IPO forms on IPO Grey Market.
- Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
- Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.
